Literature DB >> 15157953

Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.

Monika Haack1, Thomas Pollmächer, Janet M Mullington.   

Abstract

There is very little published information on the diurnal variation of cytokines and their receptors, in healthy individuals during normal sleep-wake patterns or during sustained wakefulness. The aim of the current investigation was to characterize concentrations of soluble tumor necrosis factor receptors (sTNF-Rs) and interleukin-2 receptor (sIL-2R) during normal sleep and wakefulness, as well as during a 24 h vigil. Plasma levels of the sTNF-R p55, sTNF-R p75, and sIL-2R did not differ significantly between nocturnal sleep and nocturnal wakefulness. Rhythmic analysis (2-h intervals) revealed significant diurnal variations for both sTNF-R p55 and sTNF-R p75, but not levels of sIL-2R. Diurnal variations of both sTNF-Rs were characterized by a single cosine curve with an average peak near 06:00 h in the morning. This peak occurred well before that of cortisol, and fluctuated inversely with the diurnal rhythm of temperature. These diurnal variations in sTNF-Rs levels are consistent with the hypothesis that the TNF system plays a role in normal diurnal temperature regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157953     DOI: 10.1016/j.bbi.2003.12.009

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  30 in total

1.  Negative and competitive social interactions are related to heightened proinflammatory cytokine activity.

Authors:  Jessica J Chiang; Naomi I Eisenberger; Teresa E Seeman; Shelley E Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 2.  Local sleep.

Authors:  James M Krueger; Joseph T Nguyen; Cheryl J Dykstra-Aiello; Ping Taishi
Journal:  Sleep Med Rev       Date:  2018-11-12       Impact factor: 11.609

3.  Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance.

Authors:  Kenneth P Wright; Amanda L Drake; Danielle J Frey; Monika Fleshner; Christopher A Desouza; Claude Gronfier; Charles A Czeisler
Journal:  Brain Behav Immun       Date:  2015-01-29       Impact factor: 7.217

4.  Sleep and immunity: A growing field with clinical impact.

Authors:  Mark R Opp; James M Krueger
Journal:  Brain Behav Immun       Date:  2015-04-04       Impact factor: 7.217

5.  Neural sensitivity to social rejection is associated with inflammatory responses to social stress.

Authors:  George M Slavich; Baldwin M Way; Naomi I Eisenberger; Shelley E Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

6.  TRANSLATION OF BRAIN ACTIVITY INTO SLEEP.

Authors:  James M Krueger
Journal:  Hirosaki Igaku       Date:  2012

7.  Vagotomy attenuates brain cytokines and sleep induced by peripherally administered tumor necrosis factor-α and lipopolysaccharide in mice.

Authors:  Mark R Zielinski; Danielle L Dunbrasky; Ping Taishi; Gianne Souza; James M Krueger
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

Review 8.  Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research.

Authors:  Xin Zhou; Maren S Fragala; Janet E McElhaney; George A Kuchel
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-09       Impact factor: 4.294

Review 9.  TNF revisited: osteoprotegerin and TNF-related molecules in heart failure.

Authors:  Thor Ueland; Arne Yndestad; Christen P Dahl; Lars Gullestad; Pål Aukrust
Journal:  Curr Heart Fail Rep       Date:  2012-06

10.  The effects of a muscle resistance program on the functional capacity, knee extensor muscle strength and plasma levels of IL-6 and TNF-alpha in pre-frail elderly women: a randomized crossover clinical trial--a study protocol.

Authors:  Lygia P Lustosa; Fernanda M Coelho; Juscelio P Silva; Daniele S Pereira; Adriana N Parentoni; João M D Dias; Rosangela C Dias; Leani S M Pereira
Journal:  Trials       Date:  2010-07-28       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.